Kepos Capital’s Regenxbio RGNX Stock Holding History

Kepos Capital’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-53,251	Closed	-$3.05M	–	396
2019 Q1	$3.05M	Sell	53,251 -8,619	-14%	-$427K	0.23%	126
2018 Q4	$2.6M	Sell	61,870 -6,414	-9%	-$376K	0.2%	131
2018 Q3	$5.16M	Buy	+68,284	New	+$4.92M	0.26%	93

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kepos Capital's RGNX Position: Q2 2019 in Review

Kepos Capital sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 53,251 shares — an estimated $3.05M sold.

Kepos Capital first reported a position in RGNX in Q3 2018 and held it in 3 quarters. The position peaked at $5.16M in Q3 2018. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

Kepos Capital reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
Kepos Capital sold 53,251 Regenxbio shares in Q2 2019, an estimated $3.05M.
Kepos Capital first reported a position in Regenxbio in Q3 2018 and held it in 3 quarters.
Kepos Capital's Regenxbio position peaked at $5.16M in Q3 2018.
186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on Kepos Capital's 13F filing for Q2 2019, filed 13 Aug 2019.